Fluocinolone acetonide implant (Retisert) for chronic cystoid macular edema in two patients with AIDS and a history of cytomegalovirus retinitis

Ocular Immunology and Inflammation

Volumn 19, Issue 3, 2011, Pages 206-209

  Hu, Jianmin ^a,b   Coassin, Marco ^a   Stewart, Jay M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

acquired immunodeficiency syndrome; cystoid macular edema; cytomegalovirus retinitis; immune recovery uveitis; Retisert

Indexed keywords

CIDOFOVIR; CORTICOSTEROID; FLUOCINOLONE ACETONIDE; FOSCARNET; GANCICLOVIR; PREDNISONE; TRIAMCINOLONE ACETONIDE; VALGANCICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; CATARACT EXTRACTION; CD4 LYMPHOCYTE COUNT; CORTICOSTEROID THERAPY; CYTOMEGALOVIRUS RETINITIS; DISEASE ASSOCIATION; DISEASE SEVERITY; EYE INFLAMMATION; HUMAN; IMMUNE RECOVERY UVEITIS; INTERVENTION STUDY; INTRAOCULAR PRESSURE; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; RETINA MACULA CYSTOID EDEMA; TREATMENT OUTCOME; UVEITIS; VIRUS REACTIVATION; VISUAL ACUITY; VITRECTOMY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHRONIC DISEASE; CYTOMEGALOVIRUS RETINITIS; DRUG IMPLANTS; FLUOCINOLONE ACETONIDE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MACULAR EDEMA; MALE; MEDICAL RECORDS; MIDDLE AGED; UVEITIS;

EID: 79957522474     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273948.2010.538120     Document Type: Article

References (20)

1. Kempen JH, et al. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis. Ophthalmology. 2006; 113(4): 684-694
2. Thorne, J.E., et al. Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Ophthalmology. 2006; 113(8): 1432-1440 (Pubitemid 44108166)
3. Robinson, M.R., et al., Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy. Am J Ophthalmol. 2000; 130(1): 49-56
4. Nguyen, Q.D., et al. Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy. Am J Ophthalmol. 2000; 129(5): 634-639 (Pubitemid 30323730)
5. Thorne, J.E., et al . Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Ophthalmology. 2006; 113(8): 1441-1445 (Pubitemid 44108167)
6. Zafirakis, P., et al. Cystoid macular edema in a patient with acquired immunodeficiency syndrome and past ocular history of cytomegalovirus retinitis after initiation of protease inhibitors. Doc Ophthalmol. 1999; 97(3-4): 311-315
7. Anglade, E, Whitcup SM. The diagnosis and management of uveitis. Drugs. 1995; 49(2): 213-223
8. Aukrust P, Moum B, Farstad IN, Holter E, Bjorneklett A,Kremer D. Fatal. Cytome-galovirus (CMV) colitis in a patient receiving low dose prednisolone therapy. Scand J Infect Dis. 1991; 23: 495-499
9. Hsu, J., Drug delivery methods for posterior segment disease. Curr Opin Ophthalmol. 2007; 18(3): 235-239 (Pubitemid 46624923)
10. Nguyen QD, Callanan D, Dugel P, Godfrey DG, Goldstein DA, Wilensky JT.Treating chronic noninfectious posterior segment uveitis: the impact of cumulative damage. Proceedings of an expert panel roundtable discussion. Retina. 2006;Suppl: 1-16 (Pubitemid 44622737)
11. Holland, G.N., AIDS and ophthalmology: the first quarter century. Am J Ophthalmol. 2008; 145(3): 397-408
12. Goldberg, D.E., et al., HIV-associated retinopathy in the HAART era. Retina. 2005; 25(5): 633-49; quiz 682-683
13. Raina, J., Bainbridge JW, Shah SM. Decreased visual acuity in patients with cytomegalovirus retinitis and AIDS. Eye. 2000; 14 (Pt 1): 8-12 (Pubitemid 30132989)
14. Morrison, V.L., et al. Intravitreal triamcinolone acetonide for the treatment of immune recovery uveitis macular edema. Ophthalmology. 2007; 114(2): 334-339 (Pubitemid 46161779)
15. Morrison, V.L., et al. Intravitreal toxicity of the kenalog vehicle (benzyl alcohol) in rabbits. Retina. 2006; 26(3): 339-344 (Pubitemid 44318189)
16. Jaffe, G.J., et al. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study. Ophthalmology. 2006; 113(6): 1020-1027 (Pubitemid 43795240)
17. Montero, J.A, Ruiz-Moreno JM. Intravitreal inserts of steroids to treat diabetic macular edema. Curr Diabetes Rev. 2009; 5(1): 26-32
18. Ramchandran, R.S., et al. Fluocinolone acetonide sustained drug delivery device for chronic central retinal vein occlusion: 12-month results. Am J Ophthalmol. 2008; 146(2): 285-291
19. Ufret-Vincenty, R.L., et al. Cytomegalovirus retinitis after fluocinolone acetonide (Retisert) implant. Am J Ophthalmol. 2007; 143(2): 334-335 (Pubitemid 46136145)
20. Delyfer MN, et al. Cytomegalovirus retinitis following intravitreal injection of triamcinolone: report of two cases. Acta Ophthalmol Scand. 2007;85(6): 681-683